期刊文献+

米托蒽醌与B-DNA相互作用的分子模拟 被引量:5

Molecular Modeling of the Interaction Between Mitoxantrone and B-DNA
原文传递
导出
摘要 针对嵌插型抗癌药物米托蒽醌(mitoxantrone,MTX)同B-DNA间作用模式的争议,采用分子模拟方法研究了米托蒽醌分子与B-DNA分子的相互作用.结果表明:米托蒽醌分子插入到B-DNA中有大小沟选择性及碱基对特异性,更倾向从小沟方向插入到DNA分子中;对5'-CG碱基对有特异性识别.通过详细能量项的分析,揭示了米托蒽醌插入DNA分子的驱动力及对碱基的特异性识别作用主要是空间相互作用特别是静电相互作用.在最佳作用位点复合物的构象分析则表明蒽醌环只有一部分插入碱基对中,侧链在小沟中延磷酸基骨架以3'-5'方向伸展,并通过静电作用进一步增强米托蒽醌与B-DNA的结合. Molecular modeling methods have been applied to characterization of the intercalation mode of the anticancer drug mitoxantrone (MTX) into B-DNA fragments for controversies. The results show that there are groove selectivity and base pairs specificity recognition between MTX and B-DNA, MTX prefers to intercalate into DNA from the minor groove for the base pair 5'-CG. Through analyzing the detailed energy terms of DNA-MTX, the steric interactions, especially the electrostatic interactions were found to be the main factors to the primary drive of intercalation and base pairs specificity. The conformation of MTX-DNA at the best action site shows that only a portion of the chromophore of MTX was involved in the intercalation into DNA base pairs and the binding of MTX to DNA was potentially enhanced by the presence of side chains which could bind electrostatically to the phosphate groups spreading along 3'-5' of the B-DNA.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2010年第6期551-556,共6页 Acta Chimica Sinica
基金 江苏省自然科学基金(No.BK2003080)资助项目
关键词 分子模拟 嵌插 特异性识别 B-DNA 米托蒽醌 molecular modeling intercalation specificity recognition B-DNA mitoxantrone
  • 相关文献

参考文献3

二级参考文献24

  • 1张翠萍,杨频.D,L-[Ru(phen)_2dppz]^(2+)对含G:T错配的环丁烷嘧啶二聚体识别和修复的理论研究[J].分子科学学报,2005,21(6):26-33. 被引量:3
  • 2Richard, D. W. J. Biol. Chem. 1997, 272, 23456.
  • 3Moser, J.; Volker, M.; Kool, H.; Alekseev, S., Vrieling, H.;Yasui, A.; Van Zeeland, A. A.; Mullender, L. H. F. DNA Repair 2005, 4, 571.
  • 4Mullenders, L. H. F.; Berneburg, M. J. Photochem. Photobiol.B 2001, 65, 97.
  • 5Lee, J. H.; Park, C. J.; Choi, B. S. Nucleic Acids Res. 2004,32,2474.
  • 6http://www.ncbi.nlm.nih.gov/entrcz.
  • 7Kathryn, E. E.; Duncan, T. O.; Barton, J. K. Chem. Rev.1999, 99, 2777.
  • 8Jen kins, Y.; Friedman, A. E.; Turro, N. J.; Barton, J. K.Biochemistry 1992, 31, 10809.
  • 9Harfe, B. D.; Jinks-Robertson, S. Annu. Rev. Genet. 2000,34, 359.
  • 10Buermeyer, A. B.; Deschenes, S. M.; Baker, S. M.; Liskay,R. M. Annu. Rev. Genet. 1999, 33, 533.

共引文献9

同被引文献37

  • 1马建辉.重视实体瘤疗效评价标准的变革——RECIST概要[J].中华泌尿外科杂志,2006,27(2):77-79. 被引量:39
  • 2ZHANG Dang, ZHANG Xue-jun, ZHANG Lei, et al. Anew unsymmetrical zinc phthalocyanine as photosensiti- zers for dye-sensitized solar ceils [ J ]. Bull. Korean Chem. Soc. ,2012,33(4) :1 225-1 230.
  • 3COHEN B W,LOVAASEN B M,SIMPSON C K,et al. 1000-Fold enhancement of luminescence lifetimes via en- ergy-transfer equilibration with the T1 state of Zn (TPP) [J]. Inorg. Chem. ,2010:5 777-5 779.
  • 4程林能.溶剂手册[M].北京:化学工业出版社,2000:233-234.
  • 5Bin Su, Imren Hatay, Anton n Troj nek, et al. Molecular electrocatalysis foroxygen reduction by cobalt porphyrins adsorbed at liquid/liquid interfaces[J]. J Am Chem Soc, 2010,132(8) : 2655-2662.
  • 6AIHARA M, MISUMI S. Polarographic studies of some lanthanoids in N, N-dimethylacetamide[J]. Bulletin of the Chemical Society of Japan, 1973,46 : 175-178.
  • 7Kelly J M, Murphy M J, McConnell D J. A comparative study of the intercton of 5, 10, 15, 20-tetrakis (N- methylpyridlnium4-yl) porphyrin and its zinc complex with DNA using fluorescence spectescopy and topoisomerisation[J]. Nucleic Acids Res, 1985,13(1) :167-184.
  • 8Masaaki T, Ashish K S, Elvis N. Enhanced conformational changes in DNA in the presence of mercury( II ), cadmium( II ) and lead( II ) porphyrins[J]. J Inorg Biochem, 2003,94(1/2) : 50-58.
  • 9李东红,刘建仓,刁俊林.卟啉介导抗癌药物的合成及其活性研究[J].中国药物化学杂志,2008,18(3):180-185. 被引量:5
  • 10谢雨礼,苏红.抗肿瘤药物多柔比星脂质体[J].药学与临床研究,2010,18(2):107-111. 被引量:25

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部